Four out of ten develop neurological or psychological problems 6 months after suffering from COVID-19 – Science Teach Me

Since the first studies of this new disease, there have been multiple cases where patients who survived COVID-19 developed other illnesses at or after the time of illness.

Although many of these conditions are associated with other respiratory diseases, others are associated with neurological or motor diseases; a An example is cases in which some COVID-19 patients have developed Guillain-Barré syndrome.a serious condition that occurs when the immune system mistakenly attacks part of the peripheral nervous system, resulting in nerve inflammation, resulting in muscle weakness or paralysis.

Now, the largest study published to date of the mental toll COVID-19 takes on survivors has revealed that 4 in 10 infected people outgrow the disease with a neurological or psychiatric diagnosis after six months.

In the study, researchers analyzed the health records of more than 236,379 patients who had recovered from COVID-19, and found that between 33-62% were diagnosed with a neurological or psychiatric condition after six months of suffering from the disease. In the study, the authors found that patients diagnosed with COVID-19 are more likely to develop brain diseases than those with other respiratory infections.

According to the authors, of the more than 230 thousand files analyzed, 25% were patients who were first diagnosed with a mental problem, and anxiety (in 17% of sufferers) and mood disorders were the most frequently noted. (14%). In addition, they discovered that the individual incidence of neurological disorders was rather high given the sample. Thus, intracranial hemorrhage was recorded 0-56%, apoplexy 2-10%, and dementia 17-39%.

They also noted that 46% of patients admitted to the intensive care unit were diagnosed with a neurological or psychiatric illness six months after their admission due to COVID-19, which means severe cases are at greater risk of suffering from long-term cases.

Although this data sounds a little worrying, the fact is that it occurs in a low percentage of the population affected by COVID’19, it is still a related health issue. On the other hand, the authors also comment at the end of their conclusions that more data is needed to properly assess the effects of COVID-19 on long-term brain health.

The search was published in scalpel.